Skip to main content

Table 2 Completed chemotherapy cycles and the reason of discontinuation

From: A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

Completed cyclesN
11
20
36
40
53
60
72
81
91
101
11-4
Median 5 (1–20)
 Disease progression9
 Delay due to hematologic-toxicity3
 Patient refusal2
 Protein urea1
 Pelvic abscess1
 Interstitial pneumonia1
 Nasal bleeding1
 Pulmonary thromboembolism1